New technology could aid in development of less-painful subcutaneous biologic administration
“We created the platform to provide new information to drug makers to help them better understand the amount of pain a certain injectable me
top of page
it's where dermatology lives
By John Evans
Jan 10, 20202 min read
Nrp1 a potential new target for psoriasis Tx
“These data demonstrate the therapeutic benefit of blocking Vegfa/Nrp1 interaction in the treatment of psoriatic disease, which may be safer
By John Evans
Nov 15, 20192 min read
More effective rituximab dosing for pemphigus identified
“This is the first study to provide evidence for physicians to justify a lymphoma-dose regimen of rituximab when treating their patients wit
by Cory Perla
May 16, 20191 min read
Largest of Its Kind Study Examines Safety of Systemic Treatments for Patients With Psoriasis
A large new study has evaluated the risk of infection associated with various biologic therapies for patients with psoriasis finding that th
Featured Posts
bottom of page